Project Grant R33CA263666
Award Date
9/24/21
Completion Date
8/31/25
Dollars Obligated
$4.6M
Federal Agency
National Cancer Institute
Federal Grant Program
93.353
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The National Cancer Institute (CFDA 93.398 Cancer Research Manpower) awarded a $123,888 Project Grant to President and Fellows of Harvard College (doing business as Harvard Medical School) on December 1, 2024. The grant supports research to understand the role of B cells in Merkel cell carcinoma, a rare and aggressive form of skin cancer. The research aims to determine the landscape of B cells in the tumor microenvironment and characterize their antigen-specific responses. The grant will fund...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $163,967 to President and Fellows of Harvard College (Harvard Medical School) to conduct research on defining the functional and spatial properties of tumor-specific, tumor-infiltrating CD8 T cells. The key objectives are to: Generate patient-derived xenograft (PDX) mouse models of melanoma to test the required diversity of T cell receptors (TCRs) from tumor-infiltrating T...
The Defense Health Agency awarded a $716,069 Project Grant to President And Fellows Of Harvard College, doing business as Harvard Medical School, to conduct research from September 1, 2023 through August 31, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative research and investigate medical solutions for the...
This $676,147 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports a research initiative led by Harvard University to develop data-driven biomarker-informed decision analytics to improve the efficacy and reduce the toxicity of immune checkpoint blockade therapy for melanoma patients. The 3-year project aims to leverage advanced analytics and biomarker data to optimize the use of this cutting-edge cancer...
This $1,186,517 Project Grant was awarded by the Defense Health Agency on August 1, 2023 to Harvard College President & Fellows Of Harvard T.H. Chan School Of Public Health under the Military Medical Research and Development (CFDA 12.420) program. The goal of the 3-year project is to REVEAL AND TARGET LIPIDOMIC VULNERABILITIES TO TREAT METASTATIC MELANOMA. Harvard T.H. Chan School of Public Health will conduct research to investigate new ways to treat this deadly form of skin cancer. No...
The U.S. Department of Defense's Defense Health Agency awarded a $539,904 Project Grant titled "GENOMICALLY INFORMED MORPHOLOGICAL STROMAL SIGNATURES TO PREDICT LETHAL PROSTATE CANCER" to the President and Fellows of Harvard College's Harvard T.H. Chan School of Public Health. The grant, which runs from June 15, 2025 to June 14, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically,...
This $1,014,000 project grant from the Defense Health Agency will fund research into targeted therapeutic opportunities for ovarian clear cell, small cell, and endometrioid carcinomas at President And Fellows of Harvard College from May 1, 2023 to April 30, 2027. The grant falls under the Military Medical Research and Development program, which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions. Through this...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $453,750.00 to President and Fellows of Harvard College, doing business as Harvard Medical School, from April 16, 2025 to January 31, 2030. The award will fund the development of innovative mass spectrometry-based proteomics pipelines to improve throughput, depth, and accuracy of protein abundance, post-translational...
This federal Project Grant award of $676,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Harvard Medical School to develop HUWE1 as a therapeutic target for treating mesothelioma. The award period runs from July 1, 2025 to June 30, 2027. The research aims to advance medical solutions for the battlefield and transform healthcare for military service members, veterans, and the public through innovative and impactful...
This Project Grant award of $665,616 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports the development of a novel micro-capsule technology to enable high-throughput analysis of millions of live cell-cell interactions in parallel. The technology aims to address a major unmet need in screening functional antibodies and peptides, evaluating ligand-receptor specificity, and determining cell adhesion affinities....